Statistics of Bone cancer

Executive Summary

Statistics of Bone cancer, also known as primary bone sarcoma, comprises less than 0.2% of all cancers. The chondrosarcoma has affected adults causing 40% of primary bone sarcoma. Individuals from the age group of 51 years have been diagnosed with bone sarcoma. Almost 28% of osteosarcoma, followed by 10% of chordoma, 8% of Ewing sarcoma and 4% of fibrosarcoma, have been reported in adults. 56% of osteosarcoma cases, 34% of Ewing sarcoma, and 6% of chondrosarcoma are reported in teenagers and children. The 5-year survival rate for individuals diagnosed with chordoma is 82%, 78% for chondrosarcoma, 62% for Ewing sarcoma, and 60% for osteosarcoma have been reported.

Statistics of Bone cancer

Based on Statistics on Bone cancer, Primary bone sarcoma is cancer that starts with bone. Primary bone sarcoma comprises less than 0.2% of all cancers ​1​.

In adults, chondrosarcoma makes up to 40% of primary bone sarcoma. The average diagnosis age is 51 years for bone sarcoma. The following common bone sarcoma is osteosarcoma(28%), followed by chordoma (10%), Ewing sarcoma (8%), and fibrosarcoma (4%).

In teenagers and children, osteosarcoma (56%) and Ewing sarcoma (34%) are diagnosed far more frequently than chondrosarcoma (6%). Less than 5% of chondrosarcoma and chordoma cases occur in this age group ​2​.

The 5-year survival rate reveals what per cent of people live at least five years after the cancer is found ​3​. 

Also Read: Molly Marco (Brain Cancer): Life Beyond Cancer

The 5-year survival rate for people with chordoma is 82%. 

  • The 5-year survival rate is 87% for cancer diagnosed at the localized stage. 
  • If cancer has spread to nearby tissues or organs and the regional lymph nodes, the 5-year survival rate is 83%. 
  • If cancer has metastasized, the 5-year survival rate is 55%. 

The survival rates given are the average for all types of chondrosarcoma. For people with chondrosarcoma, the 5-year survival rate is 78%. 

  • The five-year survival rate is 91% for cancer diagnosed at the localized stage. 
  • If cancer has spread to nearby tissues or organs and the regional lymph nodes, the 5-year survival rate is 75%. 
  • If cancer has metastasized, the 5-year survival rate is 22%. 

The 5-year survival rate of people with Ewing sarcoma is 62%. 

  • The 5-year survival rate is 82% for cancer diagnosed at the localized stage. 
  • If cancer has spread to nearby tissues or organs and the regional lymph nodes, the 5-year survival rate is 67%. 
  • If cancer has metastasized, the 5-year survival rate is 39%.

The 5-year survival rate of people with osteosarcoma is 60%. 

  • The 5-year survival rate is 74% for cancer diagnosed at the localized stage.
  • If cancer has spread to nearby tissues or organs and the regional lymph nodes, the 5-year survival rate is 66%. 
  • If cancer has metastasized, the 5-year survival rate is 27%.

It is noteworthy that Statistics of Bone cancer on the survival rates for people with bone sarcoma estimate can change significantly depending on several factors.

References

  1. 1.
    Franchi A. Epidemiology and classification of bone tumors. Clin Cases Miner Bone Metab. 2012;9(2):92-95. https://www.ncbi.nlm.nih.gov/pubmed/23087718
  2. 2.
    Balmant NV, Reis R de S, Santos M de O, Maschietto M, Camargo B de. Incidence and mortality of bone cancer among children, adolescents and young adults of Brazil. Clinics. Published online 2019. doi:10.6061/clinics/2019/e858
  3. 3.
    Wang Z, Li S, Li Y, et al. Prognostic factors for survival among patients with primary bone sarcomas of small bones. CMAR. Published online May 2018:1191-1199. doi:10.2147/cmar.s163229